Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution.

{
  "signal_id": "18050933-20b7-4332-8e8f-2ebd8bb20c75",
  "signal_type": "news",
  "signal_subtype": "launches",
  "detected_at": "2026-06-08T00:00:00+00:00",
  "company": {
    "name": "Illumina",
    "domain": "illumina.com"
  },
  "data": {
    "url": "https://healthtechnologynet.com/2026/06/08/illumina-launches-stratamap-spatial-solution-a-powerful-end-to-end-spatial-whole-transcriptome-research-solution",
    "title": "Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution.",
    "ticker": "NASDAQ:ILMN",
    "excerpt": "Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution.\n\nStrataMap Spatial gives researchers access to spatial biology at true single cell resolution for discovery without boundaries\n\nWhole-transcriptome profiling across a large tissue capture area can generate 2x more unique genes per sample than probe-based technologies\n\nSAN DIEGO, June 8, 2026 /PRNewswire/ - Illumina, Inc. (NASDAQ: ILMN) today announced the launch of the StrataMap Spatial Solution, offering an unmatched breadth of coverage and resolution to redefine what researchers can detect with spatial transcriptomics. StrataMap Spatial, previously called the Illumina Spatial Solution, is an end-to-end sequencing-based research solution to uncover spatial insights. Spatial transcriptomics is already a critical tool in developmental biology, neuroscience, and oncology research. StrataMap Spatial expands researchers' ability to map tissue structure, reveal tissue function, track tumor progression, and identify novel drug targets for precision medicine.\n\n\"Spatial biology offers a new perspective on how our genetic code manifests in our bodies,\" said Steve Barnard, PhD, chief technology officer of Illumina. \"Our customers are already using StrataMap Spatial's unparalleled discovery power to map intricate tissues and study tumor development. This launch pairs our new...",
    "product": "StrataMap Spatial Solution",
    "summary": "Illumina, Inc. launched StrataMap Spatial Solution on Jun 8th '26.",
    "location": "San Diego, California, United States, Northern America, Americas",
    "planning": false,
    "image_url": "https://healthtechnologynet.com/wp-content/uploads/2022/05/health-news.jpg",
    "confidence": 0.3403,
    "product_data": {
      "full_text": "StrataMap Spatial Solution",
      "fuzzy_match": true
    },
    "published_at": "2026-06-08T00:00:00Z",
    "location_data": [
      {
        "city": "San Diego",
        "state": "California",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-06-08",
    "article_sentence": "SAN DIEGO, June 8, 2026 /PRNewswire/ - Illumina, Inc. (NASDAQ: ILMN) today announced the launch of the StrataMap Spatial Solution, offering an unmatched breadth of coverage and resolution to redefine what researchers can detect with spatial transcriptomics."
  }
}

curl https://signals.autobound.ai/v1/signals/18050933-20b7-4332-8e8f-2ebd8bb20c75 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"illumina.com","limit":20}'